移植诊断市场规模、份额、成长分析、按技术、按产品和服务、按应用、按植入物类型、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球移植诊断市场规模为43亿美元，从2023年的46.2亿美元成长到2031年的82.4亿美元，复合年增长率预计为7.5%。

在器官移植需求不断增长、诊断技术进步以及导致器官衰竭的慢性疾病盛行率不断上升的推动下，全球移植诊断市场正在经历强劲增长。对准确、高效的移植相容性测试的迫切需求进一步支持了这一市场的扩张，这对于改善患者的治疗结果和成功率至关重要。一个显着的趋势是将人工智慧 (AI) 和机器学习 (ML) 整合到移植诊断中，从而可以分析包括基因组和临床资讯在内的大量资料集。这些先进技术不仅有助于识别配对模式和优化器官分配，还能显着提高诊断准确性和效率，最终改善移植手术中的病患治疗效果和资源利用率。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制因素和挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析

移植诊断市场规模：依技术及复合年增长率（2024-2031）

• 市场概况
• 分子检测技术
  • 基于PCR的分子检测
  • 即时PCR
  • 序列特异性引子PCR
  • 序列特异性寡核苷酸PCR
  • 其他基于 PCR 的分子检测
• 基于定序的分子测定
  • 桑格序列
  • 次世代定序
  • 其他基于定序的分子测定
• 非分子检测技术

移植诊断市场规模：依产品/服务及复合年增长率（2024-2031）

• 市场概况
• 试剂/耗材
• 装置
• 软体和服务

移植诊断市场规模：按应用和复合年增长率（2024-2031）

• 市场概况
• 诊断用途
  • 移植前诊断
  • 传染病检查
  • 组织相容性试验
  • 血液分析
  • 移植后诊断
• 研究用途

移植诊断市场规模：依移植类型及复合年增长率（2024-2031）

• 市场概况
• 固态器官移植
  • 肾臟移植
  • 肝臟移植
  • 心臟移植
  • 肺移植
  • 胰臟移植
  • 其他器官移植
• 干细胞移植
• 软组织移植
• 骨髓移植

移植诊断市场规模：按最终用户和复合年增长率（2024-2031）

• 市场概况
• 医院及移植中心
• 研究/学术机构
• 独立参考实验室

移植诊断市场规模与复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Abbott Laboratories（USA）
• Bio-Rad Laboratories, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Omixon Ltd.（Estonia）
• Hologic, Inc.（USA）
• Immucor, Inc.（USA）
• CareDx, Inc.（USA）
• Qiagen NV（Netherlands）
• BioGenuix, Inc.（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Fujifilm Holdings Corporation（Japan）
• Eurofins Scientific SE（Luxembourg）
• Genomatica, Inc.（USA）
• Illumina, Inc.（USA）
• Oxford Nanopore Technologies plc（UK）
• Pacific Biosciences of California, Inc.（USA）
• NanoString Technologies, Inc.（USA）
• Fluidigm Corporation（USA）
• Agilent Technologies, Inc.（USA）

结论和建议

Global Transplant Diagnostics Market size was valued at USD 4.3 billion in 2022 and is poised to grow from USD 4.62 billion in 2023 to USD 8.24 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The global transplant diagnostics market is experiencing robust growth, fueled by rising organ transplantation demands, advancements in diagnostic technologies, and increasing chronic disease prevalence leading to organ failure. This market expansion is further supported by a critical need for precise and efficient transplant compatibility testing, essential for enhancing patient outcomes and success rates. A notable trend is the integration of artificial intelligence (AI) and machine learning (ML) into transplant diagnostics, enabling the analysis of vast datasets, including genomic and clinical information. These advanced technologies not only help identify compatibility patterns and optimize organ allocation but also significantly enhance the accuracy and efficiency of diagnostics, ultimately improving patient outcomes and resource utilization in transplant procedures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplant Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplant Diagnostics Market Segmental Analysis

Global Transplant Diagnostics Market is segmented by technology, product & services, application, transplant type, end user and region. Based on technology, the market is segmented into molecular assay technologies, sequencing based molecular assays and non molecular assays technologies. Based on product, the market is segmented into reagents & consumables, instruments and software & services. Based on application, the market is segmented into diagnostic application and research applications. Based on transplant type, the market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation and bone marrow transplantation. Based on end user, the market is segmented into hospitals and transplant centers, research & academic institutes and independent reference laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplant Diagnostics Market

The Global Transplant Diagnostics market is primarily driven by the rising demand for organ transplantation procedures, largely influenced by the increasing prevalence of chronic conditions like end-stage renal disease, heart failure, and liver cirrhosis. As more patients seek effective treatments to enhance their quality of life, the recognition of organ transplantation's benefits is becoming widespread among both patients and healthcare providers. This growing awareness necessitates precise and efficient compatibility testing between donors and recipients, thereby propelling the expansion of the transplant diagnostics sector. Enhanced diagnostic methods are critical in ensuring successful transplant outcomes, further stimulating market growth.

Restraints in the Global Transplant Diagnostics Market

The Global Transplant Diagnostics market faces significant challenges due to the critical shortage of organ donors. The overwhelming demand for organ transplants surpasses the supply of suitable organs, resulting in extensive waiting lists for patients. This situation not only heightens the risk of mortality and disease advancement during these waiting periods but also hampers the performance of transplant diagnostic procedures. Consequently, the limited organ availability constrains the market potential for diagnostic products and services. Furthermore, ethical dilemmas, legal regulations, and cultural obstacles surrounding organ donation in various regions exacerbate this shortage, further restricting growth opportunities within the transplant diagnostics sector.

Market Trends of the Global Transplant Diagnostics Market

A prominent trend in the global transplant diagnostics market is the rising integration of next-generation sequencing (NGS) technology, which is transforming the landscape of organ transplantation. NGS enables comprehensive genetic profiling of both donors and recipients, significantly enhancing the matching process through detailed analysis of the human leukocyte antigen (HLA) system and other critical genetic markers. This cutting-edge approach surpasses traditional methods by accommodating a broader spectrum of HLA alleles, unveiling rare variants, and enabling the simultaneous evaluation of multiple genetic indicators. As such, NGS not only streamlines the diagnostic workflow but also holds the potential to substantially improve transplant success rates and patient outcomes through optimized donor-recipient compatibility.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Transplant Diagnostics Market Size by Technology & CAGR (2024-2031)

• Market Overview
• Molecular Assay Technologies
  • Pcr-Based Molecular Assays
  • Real-Time Pcr
  • Sequence-Specific Primer-Pcr
  • Sequence-Specific Oligonucleotide-Pcr
  • Other Pcr-Based Molecular Assays
• Sequencing Based Molecular Assays
  • Sanger Sequencing
  • Next Generation Sequencing
  • Other Sequencing Based Molecular Assays
• Non Molecular Assays Technologies

Global Transplant Diagnostics Market Size by Product & Service & CAGR (2024-2031)

• Market Overview
• Reagents & Consumables
• Instruments
• Software & Services

Global Transplant Diagnostics Market Size by Application & CAGR (2024-2031)

• Market Overview
• Diagnostic Application
  • Pre-Transplantation Diagnostics
  • Infectious Disease Testing
  • Histocompatibility Testing
  • Blood Profiling
  • Post -Transplantation Diagnostics
• Research Applications

Global Transplant Diagnostics Market Size by Transplant Type & CAGR (2024-2031)

• Market Overview
• Solid Organ Transplantation
  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation
  • Other Organs Transplantation
• Stem Cell Transplantation
• Soft Tissue Transplantation
• Bone Marrow Transplantation

Global Transplant Diagnostics Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospitals and Transplant Centers
• Research & Academic Institutes
• Independent Reference Laboratories

Global Transplant Diagnostics Market Size & CAGR (2024-2031)

• North America (Technology, Product & Service, Application, Transplant Type, End User)
  • USA
  • Canada
• Europe (Technology, Product & Service, Application, Transplant Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product & Service, Application, Transplant Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product & Service, Application, Transplant Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product & Service, Application, Transplant Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omixon Ltd. (Estonia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioGenuix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genomatica, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations